3M CO (MMM) Stock Analysis
3M CO (MMM) Stock Analysis
Analysis from 10-Q filed 2025-10-21. Data as of Q3 2025.
Overall Grade: F (Concerning)
3M CO faces challenges in financial performance that warrant careful analysis.
| Metric | Value | Context |
|---|---|---|
| ROIC | N/A | Below expectations |
| FCF Margin | 6.4% | Healthy cash flow |
| Debt/Equity | 2.7x | Elevated debt |
Investment Thesis: Financial metrics indicate concerning business quality with areas requiring attention.
Explore 3M CO: Earnings History | Filing Intelligence | ROIC Analysis
Profitability: 3M CO earns N/A ROIC
3M CO's trailing-twelve-month ROIC of N/A (sector median: -3.9%), driven by NOPAT margin of 15.8% combined with asset turnover of 0.0x. Source: 10-Q filed 2025-10-21. Gross margin of 40.9% with operating margin at 19.8% reflects strong pricing power.
| Metric | MMM | Rating | Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | N/A | Red flag | Below sector median of -3.9% |
| Gross Margin | 40.9% | Good | Strong pricing power |
| Operating Margin | 19.8% | Good | Efficient operations |
Cash Flow: 3M CO generates $1.6B FCF at 6.4% margin, positive NaN/8 quarters
3M CO generated $1.6B in free cash flow (TTM), a 6.4% FCF margin, a margin that ranks Top 25% in Healthcare. FCF was positive in N/A of the last 8 quarters. Source: 10-Q filed 2025-10-21.
| Metric | MMM | Rating | Context |
|---|---|---|---|
| Free Cash Flow Margin | 6.4% | Adequate | Healthy cash generation |
| Free Cash Flow (TTM) | $1.6B | Good | Positive cash generation |
| OCF/Net Income | 0.7x | Adequate | Potential accrual concerns |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
Balance Sheet: 3M CO at 2.7x leverage
3M CO's debt-to-equity ratio of 2.7x reflects high leverage. Total debt of $12.6B offset by $4.7B in cash. Source: 10-Q filed 2025-10-21.
| Metric | MMM | Rating | Context |
|---|---|---|---|
| Debt to Equity | 2.7x | Warning | Elevated leverage |
| Net Cash Position | $-7.9B | Warning | Net debt position |
Valuation: 3M CO trades at 24.6x earnings
3M CO trades at a P/E of 24.6x. Free cash flow yield of 1.9% reflects market expectations for growth.
| Metric | MMM | Rating | Context |
|---|---|---|---|
| P/E Ratio | 24.6x | Adequate | Premium valuation |
| EV/Sales | 3.4x | Good | Growth premium priced in |
| FCF Yield | 1.9% | Warning | Lower cash yield |
| Dividend Yield | 1.9% | Adequate | Growth focus over income |
Capital Allocation: 3M CO returns 5.9% shareholder yield
3M CO's total shareholder yield is 5.9% (dividends 1.9% + buybacks 4.1%). Source: 10-Q filed 2025-10-21.
| Metric | MMM | Rating | Context |
|---|---|---|---|
| Total Shareholder Yield | 5.9% | Good | Dividend + buyback yield combined |
| Buyback Yield | 4.1% | Good | Active share repurchases |
| Total Capital Returned (TTM) | $5.0B | Good | Dividends + buybacks returned to shareholders |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Free Cash Flow Margin | 6.4% | Top 25% | - |
| Gross Margin | 40.9% | Bottom 25% | 0.6x below |
| Operating Margin | 19.8% | Top 25% | 10.3x above |
| P/E Ratio | 24.6x | N/A | - |
Financial Scorecard
| Metric | MMM | Rating | Sector Context |
|---|---|---|---|
| Free Cash Flow Margin | 6.4% | Adequate | Top 25% of sector (median: 0.0%) |
| Gross Margin | 40.9% | Good | Bottom 25% of sector (median: 64.0%) |
| Debt to Equity Ratio | 272.3% | Warning | High financial leverage |
| P/E Ratio (Price-to-Earnings) | 24.6x | Adequate | Fair value |
| Free Cash Flow Yield | 1.9% | Warning | Growth-focused valuation |
Frequently Asked Questions
Q: What is 3M CO's Return on Invested Capital (ROIC)?
3M CO (MMM) has a trailing twelve-month Return on Invested Capital (ROIC) of N/A. This compares below the sector median of -3.9%. An ROIC below 8% suggests the company may be destroying shareholder value.
Q: What is 3M CO's Free Cash Flow Margin?
3M CO (MMM) has a free cash flow margin of 6.4%, generating $1.6 billion in free cash flow over the trailing twelve months. A FCF margin between 5-10% is typical for capital-intensive businesses.
Q: Is 3M CO stock overvalued or undervalued?
3M CO (MMM) trades at a P/E ratio of 24.6x, which is above the sector median of N/A. The EV/Sales multiple is 3.4x. Free cash flow yield is 1.9%, reflecting growth expectations priced into the stock.
Q: Does 3M CO pay a dividend?
3M CO (MMM) currently pays a dividend yield of 1.9%. Including share buybacks, the total shareholder yield is 5.9%. The relatively low yield suggests the company prioritizes growth reinvestment over income distribution.
Q: How much debt does 3M CO have?
3M CO (MMM) has a debt-to-equity ratio of 2.7x with total debt of $12.6 billion. Net debt position is $7.9 billion.
Q: What is 3M CO's revenue and earnings growth?
3M CO (MMM) grew revenue by 1.1% year-over-year. Earnings per share decreased by 21.0% compared to the prior year. Modest growth indicates a mature business with stable demand.
Q: Is 3M CO buying back stock?
3M CO (MMM) repurchased $3.4 billion of stock over the trailing twelve months. This represents a buyback yield of 4.1%.
Q: How does 3M CO compare to competitors in Healthcare?
Compared to other companies in Healthcare, 3M CO (MMM) shows: ROIC of N/A is below the sector median of -3.9% (N/Ax median). FCF margin of 6.4% exceeds the sector median of 0.0% (Top 22% of sector). Gross margin at 40.9% is 23 percentage points lower than sector peers. These rankings are based on MetricDuck's analysis of all Healthcare companies with available SEC filings.
Q: What warning signs should I watch for with 3M CO?
Investors in 3M CO (MMM) should monitor these potential warning signs: 1) Debt-to-equity of 2.7x is elevated. Regular monitoring of SEC filings and quarterly trends is recommended.
Data Source: Data sourced from 10-Q filed 2025-10-21. TTM metrics as of Q3 2025.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.
This analysis is for informational purposes only and does not constitute investment advice.